Literature DB >> 32654969

Viral Exposure Signature Associated with Liver Cancer Risk.

Naoto Fujiwara1, Yujin Hoshida2.   

Abstract

Virus infection is known to increase the risk of various cancers, including hepatocellular carcinoma (HCC). In a recent article in Cell, Liu et al. report a blood-based viral exposure signature (VES) based on a synthetic human virome to capture the history of virus exposure that is associated with future HCC occurrence.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  biomarker; hepatocellular carcinoma; viral exposure history

Mesh:

Year:  2020        PMID: 32654969      PMCID: PMC9037676          DOI: 10.1016/j.molmed.2020.06.008

Source DB:  PubMed          Journal:  Trends Mol Med        ISSN: 1471-4914            Impact factor:   15.272


  10 in total

1.  A Viral Exposure Signature Defines Early Onset of Hepatocellular Carcinoma.

Authors:  Jinping Liu; Wei Tang; Anuradha Budhu; Marshonna Forgues; Maria O Hernandez; Julián Candia; Yujin Kim; Elise D Bowman; Stefan Ambs; Yongmei Zhao; Bao Tran; Xiaolin Wu; Christopher Koh; Pallavi Surana; T Jake Liang; Maria Guarnera; Dean Mann; Manoj Rajaure; Tim F Greten; Zhanwei Wang; Herbert Yu; Xin Wei Wang
Journal:  Cell       Date:  2020-06-10       Impact factor: 41.582

Review 2.  Hepatocellular carcinoma--cause, treatment and metastasis.

Authors:  Z Y Tang
Journal:  World J Gastroenterol       Date:  2001-08       Impact factor: 5.742

3.  Global burden of cancers attributable to infections in 2012: a synthetic analysis.

Authors:  Martyn Plummer; Catherine de Martel; Jerome Vignat; Jacques Ferlay; Freddie Bray; Silvia Franceschi
Journal:  Lancet Glob Health       Date:  2016-07-25       Impact factor: 26.763

4.  Population-level impact and herd effects following the introduction of human papillomavirus vaccination programmes: updated systematic review and meta-analysis.

Authors:  Mélanie Drolet; Élodie Bénard; Norma Pérez; Marc Brisson
Journal:  Lancet       Date:  2019-06-26       Impact factor: 79.321

5.  Recurrent AAV2-related insertional mutagenesis in human hepatocellular carcinomas.

Authors:  Jean-Charles Nault; Shalini Datta; Sandrine Imbeaud; Andrea Franconi; Maxime Mallet; Gabrielle Couchy; Eric Letouzé; Camilla Pilati; Benjamin Verret; Jean-Frédéric Blanc; Charles Balabaud; Julien Calderaro; Alexis Laurent; Mélanie Letexier; Paulette Bioulac-Sage; Fabien Calvo; Jessica Zucman-Rossi
Journal:  Nat Genet       Date:  2015-08-24       Impact factor: 38.330

6.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.

Authors:  Freddie Bray; Jacques Ferlay; Isabelle Soerjomataram; Rebecca L Siegel; Lindsey A Torre; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2018-09-12       Impact factor: 508.702

7.  Use of Hepatocellular Carcinoma Surveillance in Patients With Cirrhosis: A Systematic Review and Meta-Analysis.

Authors:  Erin Wolf; Nicole E Rich; Jorge A Marrero; Neehar D Parikh; Amit G Singal
Journal:  Hepatology       Date:  2020-11-20       Impact factor: 17.425

Review 8.  A global view of hepatocellular carcinoma: trends, risk, prevention and management.

Authors:  Ju Dong Yang; Pierre Hainaut; Gregory J Gores; Amina Amadou; Amelie Plymoth; Lewis R Roberts
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2019-08-22       Impact factor: 73.082

Review 9.  Omics-derived hepatocellular carcinoma risk biomarkers for precision care of chronic liver diseases.

Authors:  Naoto Fujiwara; Tongqi Qian; Bhuvaneswari Koneru; Yujin Hoshida
Journal:  Hepatol Res       Date:  2020-05-15       Impact factor: 4.942

Review 10.  Risk factors and prevention of hepatocellular carcinoma in the era of precision medicine.

Authors:  Naoto Fujiwara; Scott L Friedman; Nicolas Goossens; Yujin Hoshida
Journal:  J Hepatol       Date:  2017-10-06       Impact factor: 30.083

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.